For most medical students, the path to the operating room is a grueling marathon of anatomy labs, clinical rotations and endless textbooks. For Maximiliano Mariné, that path was purposefully doubled. While his peers were focusing solely on the art of healing, the 24-year-old Chilean student was simultaneously mastering the precision of engineering, convinced that the future of surgery lay not just in the surgeon’s hand, but in the data streaming from the tools they use.
This dual-track obsession has led Mariné to one of the most exclusive academic intersections in the world. He has been accepted into the joint PhD program in Health Sciences and Technology (HST) offered by Harvard University and the Massachusetts Institute of Technology (MIT). The program is notorious for its selectivity; each year, roughly 900 of the world’s brightest minds apply, but only about 20 are granted admission.
Mariné’s journey is more than a story of academic endurance; It’s a case study in the emerging field of physician-engineers. By bridging the gap between clinical practice and technological innovation, he has already developed a tool that could fundamentally change how surgeons treat breast cancer, reducing costs and improving patient outcomes in real-time.
The ‘Sniff’ Innovation: Solving the Margin Problem
In breast cancer surgery, the most critical challenge is ensuring “clear margins.” This means the surgeon must remove the tumor along with a thin layer of healthy tissue to ensure no cancerous cells are left behind. If a pathologist finds cancer at the edge of the removed tissue (a positive margin) after the patient has already left the operating room, the patient must undergo a second, often distressing, surgery.
To solve this, Mariné developed “Sniff,” a device designed for intraoperative detection. The technology leverages a phenomenon common in modern surgery: the use of the electrosurgical pencil (electrobisturí), which cauterizes tissue and produces a plume of smoke. Mariné realized that this smoke contains volatile organic compounds that differ between healthy tissue and malignant tumors.
By integrating artificial intelligence with the analysis of these surgical gases, Sniff can distinguish between healthy and cancerous tissues in real-time. The disparity in accessibility is the most striking part of the innovation. Traditional gold-standard analysis—using mass spectrometers coupled with chromatographs—is prohibitively expensive and cumbersome for a standard operating room.
| Feature | Traditional Mass Spectrometry | Mariné’s “Sniff” Device |
|---|---|---|
| Approximate Cost | $400,000 | $10,000 |
| Application | Laboratory/Post-operative | Intraoperative (Real-time) |
| Core Technology | Chemical Chromatography | Gas Analysis + AI |
| Clinical Goal | Detailed Molecular Profiling | Margin Detection/Tissue Distinction |
The Logistics of a Dual Degree
Achieving a degree in both Medicine and Engineering is a feat of scheduling as much as intellect. Mariné began his journey at the Pontificia Universidad Católica de Chile, entering the medical program first. He navigated the rigid structure of medical school by leveraging the university’s flexibility regarding parallel degrees.
After completing the first year and meeting the necessary credit requirements, Mariné began integrating engineering coursework. He strategically used his medical electives to fulfill engineering requirements, effectively blending the two curricula. For six years, he balanced the “fixed” nature of the medical grid—where classes are sequenced and mandatory—with the “flexible” grid of engineering, which allowed him to slot in technical modules around his clinical duties.
“It requires double the time and double the exams,” Mariné noted, emphasizing that the primary challenge was not just the workload, but the mental agility required to switch between clinical diagnostics and engineering logic.
Cracking the Code of Ivy League Admissions
When discussing his acceptance into the Harvard-MIT HST program, Mariné dispelled the myth that a “motivation letter” is the golden ticket. According to his experience, the admissions process follows a strict hierarchy of value. First, the committee evaluates raw academic performance and GPA. Second, they look for a proven track record of research and the strength of recommendation letters from established professors.
Only after these benchmarks are met do the personal statements and future goals carry significant weight. While Mariné believes his “Sniff” project helped his application, he views it as a supplement to a foundation of academic rigor rather than a shortcut to admission.
Perhaps the most poignant part of his journey was the psychological shift. Like many students globally, Mariné initially viewed Harvard and MIT as untouchable monoliths—places reserved for the Nobel laureates seen in movies. However, a visit to Boston through a university program changed his perspective. Upon meeting students there, he realized the gap in capability was smaller than he had imagined. “I asked myself if I could be among them,” he said. “The first step was applying.”
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or surgical procedure.
Maximiliano Mariné is scheduled to begin his doctoral studies in Boston this September, where he will continue to refine the intersection of clinical medicine and health technology.
What are your thoughts on the rise of the physician-engineer? Share your perspective in the comments below or share this story with a student pursuing a multidisciplinary path.
